Related Experiment Video
Updated: Apr 22, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Vaccination of immunosuppressed patients
Marton König1, Trygve Holmøy2, Gro Owren Nygaard1
1Nevrologisk avdeling, Oslo universitetssykehus, og, Universitetet i Oslo.
Immunosuppressed patients often have weak immune systems and reduced vaccine responses, increasing infection risk. This review covers updated vaccination guidance for these vulnerable individuals.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Chronically ill patients with compromised immune systems face heightened risks of severe infections.
- Immunomodulatory therapies can exacerbate infection risks more than underlying chronic illnesses.
- Reduced vaccine responses are common in immunosuppressed populations, necessitating specialized immunization strategies.
Purpose of the Study:
- To summarize interdisciplinary knowledge regarding vaccination in patients with reduced vaccine responses.
- To inform healthcare providers about current guidance on immunizing immunosuppressed individuals.
- To address the need for tailored vaccination regimens in this patient group.
Main Methods:
- Review of interdisciplinary knowledge.
- Synthesis of current clinical guidance on adult immunization.
- Analysis of factors contributing to reduced vaccine response.
Main Results:
- Immunosuppressed patients require specific vaccination approaches due to diminished immune responses.
- Updated national guidelines emphasize the importance of tailored vaccination for this cohort.
- Understanding the interplay between disease, therapy, and immune response is crucial.
Conclusions:
- Healthcare professionals must be aware of updated vaccination protocols for immunosuppressed patients.
- Tailored vaccination regimens are essential to improve vaccine efficacy in immunocompromised individuals.
- Proactive immunization strategies can mitigate infection risks in vulnerable populations.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Vaccinations
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

